CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Editorial to the Feature article “Artemisinin anti-malarial drugs in China"
Zhang Ao
刊名Acta Pharmaceutica Sinica B
2016
卷号6期号:2页码:114
关键词Therapeutics. Pharmacology RM1-950
ISSN号2211-3835
DOI10.1016/j.apsb.2016.03.001
英文摘要The winning of the 2015 Nobel Prize in Physiology or Medicine by William C. Champbell, Satoshi Omura, and the Chinese scientist Youyou Tu marks their pioneering discoveries of novel therapeutic drugs to treat highly devastating parasitic diseases that mostly affect the world's poorest populations, such as river blindness, lymphatic filariasis, and malaria. More appreciably, this is also the first time that a Chinese scientist was awarded this Noble Prize. Professor Youyou Tu is a natural product medicinal chemist at the China Academy of Chinese Medical Sciences who made significant contribution to the discovery of artemisinin as an antimalarial drug. Back in the 1960s, malaria was the most common and widespread parasitic disease in tropical and subtropical regions, which killed millions of lives annually. Fortunately, China, under the “whole nation" system, launched a multidisciplinary drug discovery team that involved hundreds of scientists nationwide, including Youyou Tu. Their efforts led to the discovery of many antimalarial drugs or drug candidates, including artemisinin, dihydroartemisinin, artemether, and artesunate. Several of these drugs have been used since then as the standard treatment for P. falciparum and saved millions of malarial patients worldwide.
语种英语
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/283840]  
专题中国科学院上海药物研究所
作者单位中国科学院上海药物研究所
推荐引用方式
GB/T 7714
Zhang Ao. Editorial to the Feature article “Artemisinin anti-malarial drugs in China"[J]. Acta Pharmaceutica Sinica B,2016,6(2):114.
APA Zhang Ao.(2016).Editorial to the Feature article “Artemisinin anti-malarial drugs in China".Acta Pharmaceutica Sinica B,6(2),114.
MLA Zhang Ao."Editorial to the Feature article “Artemisinin anti-malarial drugs in China"".Acta Pharmaceutica Sinica B 6.2(2016):114.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace